017180 — Myungmoon Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual cashflow statement for Myungmoon Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-27,753	-6,804	7,976	-4,874	-3,790
Depreciation
Amortisation
Non-Cash Items	4,209	1,647	1,308	6,669	6,443
Unusual Items
Other Non-Cash Items
Changes in Working Capital	2,672	1,818	-8,043	-11,136	-8,032
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-16,670	864	5,480	-5,173	-1,313
Capital Expenditures	-2,438	-375	-1,948	-2,991	-1,403
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1,777	9,451	-2,984	4,813	2,371
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-661	9,076	-4,932	1,823	968
Financing Cash Flow Items	58.6	2,281	-15	0	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	21,313	-7,681	-2,503	6,455	-3,224
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3,981	2,259	-1,955	3,104	-3,570